Immune-Mediated Mechanisms in Atherosclerosis: Prevention and Treatment of Clinical Manifestations

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|36|3701-3710

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.36, 2007-12, pp. : 3701-3710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [ Immune-Mediated Mechanisms in Atheroclerosis:Prevention and Treatment of Clinical Manifestations Executive Editor: Emilio Jirillo ]

By  

Current Pharmaceutical Design, Vol. 13, Iss. 36, 2007-12 ,pp. : 3648-3648

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-inflammatory Activity of Extra Virgin Olive Oil Polyphenols: Which Role in the Prevention and Treatment of Immune-Mediated Inflammatory Diseases?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 1, 2017-12 ,pp. : 36-50

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-01 ,pp. : 4570-4582

Bentham Science Publishers

Access to resources Recommend Favorite

Nitrofurantoin: Eosinophilic lung disease, autoimmune hepatitis and immune-mediated multisystemic manifestations: case report

By  

Reactions Weekly, Vol. 1, Iss. 1415, 2012-01 ,pp. : 37-38

Adis International

Access to resources Recommend Favorite

Prevention of Immune-mediated Transfusion-related Acute Lung Injury; from Bloodbank to Patient

By  

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3241-3248

Bentham Science Publishers

Access to resources Recommend Favorite